Home / Cancer
Cancer
| 3 min read
The new diagnostic enables rapid identification of acute leukaemia patients with KMT2A rearrangements for precision therapy.
| 3 min read
Refining organoid culture methods is key to creating lifelike models for drug discovery, cancer research, and therapy testing.
| 3 min read
New research suggests an unexpected role for T cells during a tumor’s evolution from benign to malignant.
A powerful tool in modern oncology, immunotherapy doesn’t work the same for everyone. Researchers are exploring why and developing ways to improve its effectiveness.
| 2 min read
A new transformer-based model links tumor morphology with multiple genetic alterations, offering faster diagnostics and insights to guide precision oncology.
| 9 min read
Two ongoing Phase 1 trials will produce the first human data on these potentially revolutionary cancer drugs.
| 3 min read
By combining synthetic biology, computational design, and novel RNA formats, these therapies adapt in real time to disease signals, enabling previously impossible treatments.
| 4 min read
Sepsis antibody breakthroughs, a billion-dollar KRAS deal, and FDA’s push to rebuild domestic drug manufacturing led the drug discovery news this week.
| 2 min read
Industry experts and consulting firms warn that proposed import tariffs could drive up drug prices, disrupt global supply chains, and divert investment away from critical R&D pipelines.
| 4 min read
Live-cell kinetic assays provide time-resolved insights into degrader pharmacology, supporting both lead prioritization and translational modeling.
| 5 min read
Methylation profiling of cell-free DNA is opening new possibilities for detecting cancer at its earliest, pre-symptomatic stages, offering a potential breakthrough in how and when disease is found.
| 5 min read
Advances in screening and protein targeting are reviving interest in molecular glues as a strategy to tackle previously undruggable diseases.
